Search

The addition of molecular biology to the existing range of imaging technologies is creating opportunities for scientists of many disciplines. Paul Smaglik lines up the pieces.

Gifts from pioneering philanthropists have equipped the US state for a frontline battle against some of the world’s deadliest diseases.

Increasing investment in people is raising the Atlanta region's profile — and attracting a stream of internationally acclaimed researchers. Paul Smaglik reports.

This small but inventive island is putting transgenics and nanotechnology to novel uses. A pay rise might be all it needs to lure its expatriate scientists home, says Paul Smaglik.

The next generation of DNA sequencers could create more genomics jobs, says Paul Smaglik.

Michigan, Minnesota and Wisconsin have had mixed fortunes in their efforts to build up their research infrastructure. Partnerships may prove to be the strongest construction, says Paul Smaglik.

As ecologists attempt to get to grips with the Kyoto Protocol, many European climate scientists are concerned that there are insufficient resources available to understand the science behind the environment. Paul Smaglik reports.

For good reading, look more deeply, says Paul Smaglik.

What makes the Mesa so attractive to pharmaceutical companies? Paul Smaglik investigates.

Can the intellectual route from China to the United States become a two-way street? Paul Smaglik investigates.

We all know a special person who has inspired us. Paul Smaglik learns from the winners of the first UK award for excellent mentoring in science.

An alliance of universities in the north of England hopes to transform Britain's former industrial heartland into a centre of scientific excellence. Paul Smaglik reports.

Specialization may be the key to success as divisions between big and small genomics centres continue to grow, say Potter Wickware and Paul Smaglik.

A bold scheme to map the entire human brain has become the mission of many scientists from a host of different fields. Paul Smaglik tracks the interdisciplinary career implications.

New Mexico, with its national labs and natural resources, is poised to become a central player in the US race for energy independence. Paul Smaglik reports.

Recruitment of chemists in traditional bulk commodities and manufacturing may be slumping, but fresh opportunities are opening up for those whose skill sets are amenable to biotechnology applications, say Claudia Caruana and Paul Smaglik.

The industrial revolution that is reshaping structural biology is opening doors of opportunity for computer scientists and protein chemists alike, says Paul Smaglik.

At last nanotechnology is moving from the realm of hype and hope into the real world, with jobs and funding appearing on both sides of the Atlantic. Paul Smaglik considers the options.

The biotech scene, although volatile, will continue to provide jobs. But potential employees should prepare for a bumpy ride, say Paul Smaglik and Adam Smith.

Researchers seeking the latest biotechnology expertise have several options. Paul Smaglik reports.

Researchers who aspire to work in drug discovery need to adapt to constantly changing technology and be able to harness new tools both to ask and to answer pertinent scientific questions, say Paul Smaglik and Adam Smith.

A former researcher's career path shows how one can stay connected to academic science.

Translating global science extends beyond language.

Rebuffing a troubled economic and political past, Argentina is trying to get on the science map with a new science ministry and attempts to retain young talent. Paul Smaglik reports.

US researchers are keen to find ways to address health disparities among minorities. Paul Smaglik reports.

New frontiers in basic chemistry could drive applied science in many fields. But support for basic research seems to be waning, in both academia and industry. Paul Smaglik dons his lab coat.

Postdocs are attempting to organize and improve their lot worldwide — but results have been mixed. Paul Smaglik reports.

Skills in genetics and clinical research are in demand as academia and industry try to tailor treatments to their patients, says Paul Smaglik.

Pools of latent HIV, lurking in the cells of infected people, remain untouched even by powerful drug combinations. Paul Smaglik reports on how this is forcing researchers to rethink their strategies for fighting the virus.

Academic and government labs in the Chicago area are combining forces to reel in a host of large collaborative research projects — and tens of millions of dollars in funding. Paul Smaglik sums up.

Is it possible to produce a complete mathematical description of complex biological systems? Leroy Hood thinks so, as Paul Smaglik discovers.

Huntsville, Alabama, the original home of NASA and of military weapons development, makes a move into biology. Paul Smaglik reports from Rocket City.

Pittsburgh's universities are helping the city to emerge from its Rust Belt roots and forge a knowledge economy. Paul Smaglik reports.

No longer rivals, Oxford, Cambridge and London are now working towards a common goal — ensuring the 'golden triangle' becomes a global science hub.

Career planning requires a good bit of introspection.

A controversial move to central London for the Medical Research Council's flagship lab will have career repercussions.

Washington

Legislation altering the oversight of all federally funded human clinical gene therapy trials was introduced into the US House of Representatives last week.